Bacteria-responsive programmed antibacterial liposome to modulate the inflammatory microenvironment for intracranial methicillin-resistant Staphylococcus aureus infections
dual mechanisms: direct disruption of bacterial membranes and photodynamic action. Animal experiments further verify that QAI-lipo exerts anti-inflammatory activity by inhibiting the MyD88/TRAF-6 signaling pathway, which downregulates the expression of downstream proinflammatory cytokines and upregulates that of anti-inflammatory factors. Moreover, QAI-lipo attenuates the activation of inflammatory cells (including microglia and astrocytes) and suppresses proinflammatory microglial polarization, ultimately improving the survival outcomes of infected animals. This platform offers a general strategy for central nervous system drug delivery and holds promise for broader therapeutic applications, such as the treatment of bacteremia and sepsis.
Authors
- Shiqi CHENG
- Yong Zhang (ORCID: https://orcid.org/0000-0003-4724-9885)
- Raorao Yuan
- Yan Li (ORCID: https://orcid.org/0000-0002-9431-6457)
- Hengyi Fan
- Pan Lei
- Yangyang Zhao
- Yi Zhuo (ORCID: https://orcid.org/0000-0001-5640-8951)
- Yan Zhang
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Journal of Materials Chemistry B
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1039/d6tb01667g
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province